Sarepta Therapeutics (SRPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kostas ...

H.C. Wainwright lowered the firm’s price target on Sarepta (SRPT) to $75 from $80 and keeps a Sell rating on the shares. Sarepta’s deal to ...

M&A dealmaking activity is about to boom, according to Goldman Sachs. Here's how you can leverage that for index-beating ...

Hailing from Belgharia in Kolkata, 22-year-old Sayan Ghosh had traveled to Bangladesh on November 23. He stayed with a friend’s family.